Special Issue "Induced Impairment of Neurogenesis and Brain Diseases"
Deadline for manuscript submissions: closed (31 July 2022) | Viewed by 44484
A printed edition of this Special Issue is available here.
Interests: radiobiology; neurogenesis; neurodegeneration; neurological and neuropsychological disorders
Special Issues, Collections and Topics in MDPI journals
Impairment of neurogenesis can be induced after pre-and post-natal chemical and biological toxin, alcohol and radiation exposure, drug treatment, hormone imbalances, stress, pain, hypoxia, brain trauma, malnutrition, aging. It also occurs in genetic disorder such as Down syndrome (DS), autism, fragile X syndrome (FXS), neurological disorders including Alzheimer's disease (AD), Parkinson's disease (PD) epilepsy, Huntington's disease (HD) and neuropsychological disorders including depression, schizophrenia although the causal relationship between impairment of neurogenesis and neurological and neuropsychological disorders remains unknown. In this special issue of “Cells” entitled “Induced Impairment of Neurogenesis and Brain Diseases”, I invite you to submit animal or cell experimental research work and review papers to discuss different causes of the impairment of neurogenesis, relevant neurobehavioral changes, molecular mechanisms and therapeutic approaches. It is aimed to update researchers and clinicians about the complexity of the development of impairment of neurogenesis, the importance of the involvement of impairment of neurogenesis in neurological and neuropsychological disorders and to provide some clues for design novel therapeutic approaches by targeting impairment of neurogenesis to effectively prevent or treat different genetic, neurological and neuropsychological disorders.
Dr. FengRu Tang
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- chemical and biological toxin
- genetic disorder, brain trauma
- neurological and neuropsychological disorders